Clinical Trials in Dallas

Showing 14261-14280 of 17,468 trials

Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001

NCT01369615

The purpose of this study is to characterize the long-term safety of oxycodone hydrochloride (HCl) controlled-release (CR) tablets in opioid experienced pediatric patients aged 6 to 17 years, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid therapy who completed the 4 -week treatment period in OTR3001.

Pain

Purdue Pharma LP23 participantsStarted Oct 2011

Birmingham, Alabama, United States • Paramount, California, United States • Aurora, Colorado, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

NCT01730040

This is a randomized, double-blind, active-comparator, parallel-group study in patients at high cardiovascular risk with nonfamilial hypercholesterolemia or heterozygous familial hypercholesterolemia (heFH).

Hypercholesterolemia

Regeneron Pharmaceuticals355 participantsStarted Oct 2012

Mobile, Alabama, United States • Chandler, Arizona, United States • Tucson, Arizona, United States +94 more locations

Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001

Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

Find Trials by Condition in Dallas

Effect of Febuxostat on Blood Pressure

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

Phase III Study in Refractory Behcet's Disease

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects

Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)

fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

Multiple Ascending Dose (MDX1105-01)

huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Gadobutrol Enhanced MRA of the Renal Arteries

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Surgical Reduction of the Inferior Turbinates for Nasal Obstruction

Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis

OTO-104 for the Treatment of Meniere's Disease

Induction-maintenance of Lopinavir/r in HIV-infected Subjects